A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The breakpoints of Df(2R)BSC828 predicted from the Release 5 genomic coordinates of the progenitor P{XP}par-1d08945 and PBac{WH}hrgf06255 transposable element insertion sites are 2R:15351032 ;15552519 and the cytological breakpoints predicted from these coordinates are 56D10;56E1.